Webinars

Each month, ALS TDI brings together researchers from our lab and others for a conversation about an important topic to patients today. These can be on a specific trial, an emerging technology, or a broad theory gaining notoriety in the effort to combat ALS. These conversations are designed to ask these researchers direct questions and to provide a place where YOU and YOUR family can speak directly to those working on your behalf at ALS TDI and other labs. These webinars are recorded, but we encourage folks to join us live as your questions and interaction with these researchers is incredibly important.

This Month - ALS Unfiltered 2017 Webinar: How do drugs get approved in the United States?

In this webinar we will discuss the FDA and the drug approval process in the United States. There is a lot of hope at the moment for new treatments so we want to make sure the community is fully informed about the FDA's role in this process. We will talk about the various steps, timelines and milestones that sponsors must go through to get an FDA approved drug to market. We will also touch upon what a persons options are with regard to Compassionate Use and Right to Try.´╗┐

 

Presenter: Rob Goldstein

Register to Watch

Previous Webinars

How do drugs get approved in the United States? (May 17, 2017)

FDA approves Radicava - What do we need to know? (May 10, 2017)

ALS Unfiltered Webinar: Top 10 Things in ALS Research to Watch for in 2017 (February 9, 2017)

Recap of ALS/MND Research Symposium in Dublin, Ireland (December 20, 2016)

Masitinib, Radicut, NurOwn: What you need to know NOW. (August 18, 2016)

Precision Medicine Program Expansion: PMP 2.0 (July 27, 2016)

 

Looking for a way to join us in the fight to end ALS?

There are over 300 events that together raised $100 million to support our mission. Will you help?

 

 

Favorable Mentions

I am committed to give all I can because I know the people at TDI are commited to give all they can as we research for treatments and a cure.

ALS TDI undoubtedly sets themselves apart. It's a nimble organization that can react quickly to research opportunities, provide donor confidence through transparency and keeps their main focus on treatments. With their hallways filled with photos of ALS fighters from yesterday and today... I felt like this organization has their eyes on the prize, speed to a cure.

ALS TDI puts a face on ALS research. I'm sure there is other good research being done, but it's not as accessible as ALS TDI. It means a lot to know they actively make sure the ALS community is central to their work.